PROVECTUS BIOPHARMACEUTICALS, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) had Lessee, Operating Lease, Liability, to be Paid, Year One of $12.84 thousand as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2024-11-12
- 2024-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $12.84K.
- 2024-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $25.67K.
- 2024-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $38.17K.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $50.66K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2024-09-30 | $12.84K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $25.67K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $38.17K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $50.66K 10-K · filed 2024-03-28 |
| 2023-09-30 | $50.66K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $50.66K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $50.66K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $49.31K 10-K · filed 2023-03-30 |
| 2022-09-30 | $49.31K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $49.31K 10-Q · filed 2022-08-11 |
| 2021-12-31 | $46.69K 10-K · filed 2022-03-29 |
| 2021-09-30 | $46.69K 10-Q · filed 2021-11-10 |
| 2021-03-31 | $46.69K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $92.47K 10-K · filed 2021-03-02 |
| 2020-09-30 | $92.47K 10-Q · filed 2020-11-12 |
| 2019-12-31 | $90.67K 10-K · filed 2020-03-05 |